Ampio Pharmaceuticals
AMPE
$0.26
Share price
1.19%
Change (1 day)
21.43%
Change (1 year)
Categories
Operating Margin for Ampio Pharmaceuticals (AMPE)
Operating Margin as of May 2024 (TTM): -2,900.24%
According to Ampio Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -2,900.24%. At the end of 2015 the company had an Operating Margin of -2,900.24%.
Operating Margin history for Ampio Pharmaceuticals from 2012 to 2015
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2015 | -2,900.24% | -94.3% |
| 2014 | -50,853.58% | 3.66% |
| 2013 | -49,056.85% | 111.58% |
| 2012 | -23,186.23% | -76.21% |
| 2011 | -97,475.91% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -100.79% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -101.19% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | -100.54% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 37.68% | -101.30% | 🇺🇸 USA |
 Rigel Pharmaceuticals RIGL | -11.59% | -99.60% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | -79.07% | -97.27% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -10.86% | -99.63% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.